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OBJECTIVES: Osteoporotic vertebral compression fractures (OVCFs) affect the elderly population, especially
postmenopausal women. Percutaneous kyphoplasty is designed to treat painful vertebral compression fractures
for which conservative therapy has been unsuccessful. High-viscosity cement can be injected by either a hydraulic
pressure delivery system (HPDS) or a balloon tamp system (BTS). Therefore, the purpose of this study was to
compare the safety and clinical outcomes of these two systems.
METHODS: A random, multicenter, prospective study was performed. Clinical and radiological assessments were
carried out, including assessments of general surgery information, visual analog scale, quality of life, cement
leakage, and height and angle restoration.
RESULTS: Using either the HPDS or BTS to inject high-viscosity cement effectively relieved pain and improved the
patients’ quality of life immediately, and these effects lasted at least two years. The HPDS using high-viscosity
cement reduced cost, surgery time, and radiation exposure and showed similar clinical results to those of the
BTS. In addition, the leakage rate and the incidence of adjacent vertebral fractures after the HPDS treatment
were reduced compared with those after treatment using the classic vertebroplasty devices. However, the BTS
had better height and angle restoration abilities.
CONCLUSIONS: The percutaneous HPDS with high-viscosity cement has similar clinical outcomes to those of
traditional procedures in the treatment of vertebral fractures in the elderly. The HPDS with high-viscosity
cement is better than the BTS in the treatment of mild and moderate OVCFs and could be an alternative method
for the treatment of severe OVCFs.
KEYWORDS: Osteoporotic Vertebral Compression Fractures; Percutaneous Kyphoplasty; Percutaneous Verteb-
roplasty; Hydraulic Pressure Delivery System; Balloon Tamp System; High-Viscosity Cement.
’ INTRODUCTION
Osteoporotic vertebral compression fractures (OVCFs)
are a common cause of pain and disability in people over
50 years old, especially in elderly women. Osteoporosis affects
44 million Americans (1) and 27.5 million Europeans (2). In
the year 2000, the number of osteoporotic fractures world-
wide was estimated to be nine million, of which 1.4 million
were vertebral compression fractures (3). Percutaneous
kyphoplasty (PKP) and percutaneous vertebroplasty (PVP)
are currently used for the management of painful OVCFs
that fail to respond to conventional therapies.
Many studies have compared the clinical results of PVP
and PKP. Both of these procedures are based on the injection
of medical cement into a collapsed vertebral body, resulting
in immediate and sustained pain relief (4-6). The main com-
plication and cause for concern among surgeons and patients
is the cement leakage. Leakage, which is the extravasation ofDOI: 10.6061/clinics/2019/e741
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cement beyond the confines of the collapsed vertebral body,
results in not only minor complications without special therapy
and short- or long- consequences but also major complications
such as urgent laminectomy decompression and embolism.
Classical PVP consists of the injection of a low-viscosity
cement into the fractured vertebra using a push rod at a high
pressure, which results in either a small amount of injected
cement or more cement extravasation. To improve this
situation, PKP is performed in which an inflatable device
such as a balloon is inserted. Using this method, even a ball
of high-viscosity cement could be injected into the fractured
vertebral body and inflated to elevate both endplates to
create a cavity. In addition, the cement is injected into
the cavity at a low pressure, significantly decreasing the
potential of extravasation (7). Hulme et al. reviewed the
clinical studies regarding these two procedures and found
that the mean rate of cement leakage due to PVP was of 41%
and that due to PKP was 9% (8). Other evidence confirmed
that PKP results in less cement leakage than does PVP (9,10).
A meta-analysis reported by Eck JC et al. showed greater
improvement in pain scores when PVP was used instead of
PKP, but there was less new fracture after PKP (14.1%) than
after PVP (17.9%) and less cement leak risk after PKP (7.0%)
than after PVP (19.7%) (11).
Some studies reported that an increase in viscosity from low
to medium can reduce cement extravasation (12-14), which is
completely avoided when poly (methyl methacrylate) (PMMA)
reaches high viscosity and achieves a dough-like consistency.
Nevertheless, the classical syringe, cannula, and push rod
cannot inject a cement with such high viscosity. To solve this
problem, a new hydraulic cement delivery system was
developed that can inject highly viscous cement into the
collapsed vertebral body without using balloon expansion
to create a cavity. By using this system, the cement extrava-
sation rate could probably decrease, reducing complications
arising from the cement leakage. The balloon tamp system
(BTS), which holds the cement in the vertebral body, was
considered the critical reason for the difference in leakage rate
(15). Moreover, cement viscosity and injection volume were
considered other main factors influencing cement extra-
vasation (16). Therefore, we wondered if we could inject
high-viscosity cement using a hydraulic pressure delivery
system (HPDS) without the need to create a cavity with the
BTS. To answer this question and to compare the safety and
efficacy of HPDS and BTS using the high-viscosity cement in
the treatment of OVCF, we performed the following prospec-
tive clinical study.
’ MATERIALS AND METHODS
Study design and participants
A randomized, controlled, four-center prospective study
was performed to compare the clinical outcomes of HPDS
or BTS using high-viscosity cements for relieving pain and
restoring the physical functions in people with painful OVCFs.
The Institutional Review Board approved this study, and
the patients provided informed consent prior to the study.
Four hospitals were involved in this study, and enrollment
started in April 2014 and continued through January 2016;
the follow-up period was two years. As described previously
(17,18), the study inclusion and exclusion criteria are shown
in Figure 1.
Interventions and surgical procedures
At baseline, the demographic and clinical information,
including age, gender, smoking status, bone mineral density,
medicine use, fracture history and vertebral fracture nature,
was collected 1 day to 1 week before randomization. All
surgeons in this trial belonging to the four participating
hospitals were experienced and had performed more than
50 procedures. The participants were randomly assigned to
undergo either HPDS or BTS surgery, and steps were taken
to make sure that the participants remained unaware of their
assigned intervention (Figure 2).
Figure 1 - Inclusion and exclusion criteria.
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The prone position was used when sedation and analgesia
were induced in the patients. After the fractured vertebral
body and its corresponding pedicles were located using fluo-
roscopy (Figure 3), the surgical procedures were conducted
under local or general anesthesia. All participants received
cephalothin administered intravenously 30 min before
puncture. Under fluoroscopic guidance, beveled injection
needles were punctured into the thoracic vertebra or the
vertebral arch in the lumbar vertebra. Then, the patients
underwent the HPDS or BTS procedure according to their
random assignment.
For the HPDS procedure, once the needle was punctured
into the center of the vertebra, a high-viscosity bone cement
was prepared by mixing the powder and liquid components
until a paste was formed. Then, PMMA was loaded into
a bone cement perfusion apparatus (Zhongshan Shiyitang
Medical Devices Co., Ltd., China) and manually injected into
the target vertebra using the HPDS under constant lateral
fluoroscopic guidance (Figure 4).
For the BTS procedure, a bone drill was used to create
a working channel according to well-established methods.
Next, an inflatable balloon tamp (Shanghai Kinetic Medi-
cal Co., Ltd., China) was inserted into the center of the
vertebral body, followed by sequential pressure-controlled
inflation of the balloon to create a cavity. The bone cement
was then mixed and manually injected into the cavity
(Figure 5) (19).
In both groups of patients, the cement injection was stopped
when 1) the cement reached the posterior wall of the fractured
vertebral body, 2) a substantial resistance was detected during
injection, 3) the presence of radiologically adequate filling was
reached, or 4) a potential leakage was suspected.
Following the surgery, the patients rested for 6 hours, and
their vital signs and neurologic symptoms were monitored
for up to 24 hours.
Clinical and radiological assessments
The patients received written evaluation questionnaires
that were mailed, emailed, or shared via WeChat 3d before
and 1 w, 3 m, 6 m, 12 m and 24 m after the surgery.
The clinical assessment included: (1) surgery information
including the average surgery time (incision to suturing/
number of treated vertebral levels), X-ray exposure times
during the surgery, injected cement dosage, and cost of
hospital stay; (2) a visual analog scale (VAS) for overall pain;
(3) the modified Roland-Morris Disability Questionnaire
(RDQ) (17,20,21); (4) the European Quality of Life–5 Dimen-
sions (EQ–5D) scale(17,22); (5) the Short Form-36 General
Health Survey (SF-36) including the physical component
summary (PCS) and the mental component summary (MCS)
for the quality-of-life evaluation; (6) the Oswestry Disability
Index (ODI) for functional assessment; and (7) surgery related
complications. The primary outcome measures were the VAS
scores for back pain and the modified RDQ.
Figure 2 - Participant enrollment, assigned Intervention, and follow-up.
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The radiological assessment included: (1) cement leakage;
(2) vertebral height restoration; (3) vertebral wedge angle; and
(4) adjacent vertebral fracture at final follow-up. The vertebral
height restoration percentage was calculated as follows (23):
vertebral height restoration percentage = (anterior or middle
height postoperation – anterior or middle height preopera-
tion) / (anterior or middle height preoperation)  100%. The
vertebral wedge angle was equal to the angle between the
upper and lower endplates of the vertebral body before and
after the operation (24).
Statistical analysis
The continuous variables were analyzed using Student’s
t-test. The categoric variables were assessed using the w2 test.
The results are presented as the mean±SD. A p valueo0.05




A total of 1216 potential patients were identified from 2014
to 2016, but only 289 of those met the inclusion criteria and
underwent randomization (143 in the HPDS group and 146
in the BTS group). Three participants (2%) in the HPDS group
and five (3%) in the BTS group were lost to the 1 w follow-
up. At the 2-year follow-up, complete data were available for
30 of the 143 participants (21%) in the HPDS group and 31 of
Figure 4 - HPDS surgical procedure for the treatment of a 79-year-old female patient with T8 vertebral body fracture. A, A puncture
needle enters into the fractured T8 vertebra via the left pedicle. B, Lateral radiograph showing the puncture needle tip in the anterior
column of the vertebral body. C, High-viscosity bone cement is injected into the fractured vertebral body. The lateral radiograph shows
the filling of the vertebral body with high-viscosity cement. D and E, Lateral and posterior-anterior X-ray films after the HPDS surgical
procedure. F, The HPDS device and high-viscosity cement.
Figure 3 - Typical X-ray and magnetic resonance (MR) images
of OVCFs. A and B, Posterior-anterior and lateral X-ray films
showing a compression fracture in T12. Both endplates were
fractured. C and D, MR images showing marrow edema in the
fractured vertebral body.
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the 146 participants (21%) in the BTS group. The baseline
characteristics of the two groups were similar and are
summarized in Table 1. There was no statistically significant
difference in the bone mineral density T-score, medicine usage,
severity of fracture, fracture distribution and demographic
data such as gender and age. No significant difference
was found between the two groups regarding the VAS and
quality-of-life scores, such as RDQ, EQ-5D, SF-36 and ODI
before surgery. If the participants were lost to follow-up at
one time point, they were not recorded in the following
follow-up.
General surgery parameters
The mean surgery times were 35 min for the HPDS group
and 45 min for the BTS group (po0.05). The mean X-ray
exposure times were 45 times for the HPDS group and 72 times
for the BTS group, and the difference was significantly dif-
ferent (po0.05). The surgery time and X-ray exposure time
of the puncture procedures were longer than those of the
other procedures, and no significant difference was observed
between the HPDS and BTS groups. The surgery time and
X-ray exposure time of the balloon augmentation procedure
were longer for the BTS group than for the HPDS group.
The injected cement volumes were 3.5±1.1 mL for the HPDS
group and 4.7±1.5 mL for the PKP group. Thus, the injected
cement dose used to perform BTS was more than the dose
injected using the perform HPDS. However, a larger dose of
cement than that injected when performing the classical PVP
with low-viscosity cement was used to inject high-viscosity
cement using the HPDS. The BTS was more expensive than the
HPDS because of the high cost of the balloon tamp (Table 2).
Pain and functional evaluations
The pain and functional evaluations were recorded
and are shown in Table 3. VAS and RDQ were the primary
outcomes. No significant difference between the HPDS
and BTS groups was found regarding the primary outcome
of the overall pain in VAS and RDQ postoperation (PO).
A significant difference (po0.05) in the VAS and RDQ
scores was observed before and 1 w after surgery, indi-
cating that all patients experienced pain relief and mobility
improvement immediately after surgery. Moreover, the
2-year follow-up results showed that the VAS scores PO
did not change. Therefore, both HPDS and BTS using high-
viscosity cement resulted in significant pain relief and the
improved recovery of functional abilities. The mean
reductions in the VAS scores of the HPDS and BTS groups
were 2.9±2.1 and 3.3±2.3, respectively, but the difference
between these values was not statistically significant. No
significant difference in any other secondary parameter was
observed between these two groups over time, except for
SF-36 PCS 3 m and 6 m PO, EQ-5D 12 m and 24 m PO, and
ODI 3 m, 6 m and 12 m PO. The use of analgesics, NSAIDS
or opioids decreased over the 12 months follow-up, with
no significant difference between the two groups. How-
ever, analgesic use increased after 24 months compared
with that after 12 months, and the VAS increased after
24 months compared with that after 12 months. The reason
for these differences might be the new fracture forma-
tion. The RDQ scores before surgery were 15.1±3.1 for
the HPDS group and 15.5±2.3 for the PKP group, and
these values decreased to 13.1±2.1 and 12.8±2.0 one week
after surgery, respectively. Both the HPDS and BTS groups
showed sustained improvement for at least 2 years, and
Figure 5 - BTS surgical procedure for the treatment of a 75-year-old male patient with T12 vertebral body fracture. A, A puncture
needle enters into the wedge T12 vertebra via the left pedicle. B, A bone drill was inserted in the fractured vertebral body to drill a
circular hole as a working channel. C, An expandable cannula was inserted into the fractured vertebral body, and the balloon was
slowly inflated. D and E, Posterior-anterior and lateral X-ray films after the BTS surgical procedure. F, The BTS instruments.
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similar improvement was observed in these two groups.
There was no significant difference in the secondary out-
comes such as EQ-5D, SF-36 and ODI (Figure 6).
Radiological evaluations
The X-ray films were analyzed to measure the cement
extravasation, height restoration percentage, wedge angles and
adjacent vertebral fractures after surgery (Table 4). The leakage
rate in the BTS group was lower than that in the HPDS group.
Better height restoration in the anterior and middle vertebral
body and wedge angle was observed after the BTS interven-
tion. Therefore, when high-viscosity cement was used, both the
HPDS and BTS restored the height of the vertebral body
significantly. The BTS group had significantly higher height and
wedge angle restoration than the HPDS group (po0.05).
Therefore, both the HPDS and BTS treatments enabled height
restoration, although the BTS treatment resulted in a better
outcome. The vertebral anterior and middle height restoration
percentages for severe fractures in the HPDS group were 5.6
±4.4 and 10.3±4.9, respectively, while those in the BTS group
were 15.6±6.1 and 27.5±12.1, respectively, suggesting that the
BTS resulted in better height restoration in severe fractures than
in mild and moderate fractures. The percentages for adjacent
vertebral fractures were 13% after the HPDS treatment and 16%
after the BTS treatment.
’ DISCUSSION
OVCFs are usually painful for patients and affect more
women, especially postmenopausal women, than men. PVP
and PKP are currently widely used vertebral augmentation
procedures for treating painful OVCFs when conservative
therapy is not effective. Vertebral body augmentation stabi-
lizes the fractured vertebral body through infused PMMA
without increasing mortality (4,25). PMMA monomers used
to reduce pain are cardiotoxic, while the polymerization of
PMMA monomers causes thermal injuries to the surrounding
tissues. High-viscosity cement injections lower the potential
for cardiovascular complications (26) and have been shown
to significantly reduce the leakage rate and frequency of
leakage-related complications compared with low-viscosity
cement injections (27-29). Thus, the use of high-viscosity
cement in a new device for vertebral augmentation could
be promising.
Table 1 - Baseline characteristics and clinical data of the patients.
Characteristic HPDS BTS
Age (mean±SD) 72.1±9.2 71.1±8.6
Female - no. (%) 104 (73) 110 (75)
Current smoker - no. (%) 23 (16) 21 (14)
Bone mineral density T-score -2.66±0.89 -2.72±0.76
Medication for osteoporosis - no. (%)
Any 128 (90) 135 (92)
Calcium supplements 117 (82) 115 (79)
Vitamin D 74 (52) 70 (48)
Bisphosphonates 36 (25) 32 (22)
Previous vertebral fractures - no. (%) 53 (37) 50 (34)
Pain duration (week, mean±SD) 6.8±3.2 7.1±4.1
VAS during the past 24 hours (mean±SD) 7.1±1.2 7.3±1.1
Use of analgesic (NSAIDS or opioids) - no. (%) 105 (73) 112 (77)
Severity of fracture - (%)
Mild 44 (31) 42 (29)
Moderate 69 (48) 76 (52)
Severe 30 (21) 28 (19)
Number of treated vertebral levels - no. (%) 201 (100) 218 (100)
1 98 (69) 95 (65)
2 32 (22) 30 (21)
3 13 (9) 21 (14)
Fracture distribution - no. (%)
Thoracic 145 (72) 168 (77)
Lumbar 56 (28) 50 (23)
RDQ (mean±SD) 15.1±3.1 15.5±2.3




ODI (mean±SD) 62.6±8.2 61.5±7.5
No significant differences in the baseline data between the two groups were found.
Table 2 - Surgery parameters (mean±SD, minimum-maximum).
HPDS BTS
Average surgery time per vertebra (min) 35±19 (15-52) 45±21* (25-71)
X-ray exposure times 45±22 (31-122) 72±25* (65-182)
Injected cement dosage per vertebra (ml) 3.5±1.1 (1.3-5.2) 4.7±1.5* (2.4-7.3)
Cost (dollars) 4570±860 (3610-5680) 5230±980* (4250-7820)
*po0.05 versus HPDS.
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The surgery time for the HPDS group was significantly
shorter than that of the BTS group. The time spent on the
puncture and injection steps was almost the same for these
two groups. The time used to apply the balloon was longer
for the BTS group than for the HPDS group. In addition, the
balloon application and expansion step for the BTS resulted
in longer X-ray exposure time; injecting high-viscosity cement
using the new HPDS reduced the need for bone tamps in
the BTS, significantly reducing the number of steps in the
procedure and the surgery time.
Both the HPDS and BTS resulted in pain reduction
immediately after the operation that lasted at least 2 years.
The VAS in both groups was better than that before the
surgery, and no significant differences were found between
these two groups in 1 w, 1 m, 3 m, 6 m and 12 m PO.
Furthermore, after reviewing the PO data in the mild and
moderate fracture subgroups, we found no significant differ-
ence between the HPDS and BTS; however, in the severe
fracture subgroup, the VAS in the BTS (4.2±0.9 and 5.3±1.4)
was significantly better than that in the HPDS (4.9±0.8 and
5.9±1.3) in 12 m and 24 m PO, respectively. These findings
indicated that the BTS may result in better pain relief
in patients with severe fracture 1 year PO than the HPDS.
We used the RDQ, EQ-5D, SF-36 and ODI to evaluate life
quality, disability and functional recovery. A clear improve-
ment in the life quality of both HPDS and BTS groups was
observed that lasted at least 2 years. There was no significant
difference between the HPDS and BTS groups in the PO
scores of RDQ, SF-36 MCS, ODI, most of the SF-36 PCS and
EQ-5D.
The HPDS using high-viscosity cement significantly
decreased the leakage rate compared to PVP using low- to
medium-viscosity cement(29). PKP had excellent abilities in
vertebral height and kyphotic angle restoration. The verteb-
ral height and kyphotic angle restoration in the HPDS group
were less than those in the BTS group because of the position
of the patient, although the cement injected into the vertebral
body slightly restored the height and angle. The inflation of a
balloon tamp inside the vertebral body plays an important
role in height and angle restoration. This observation explains
why the BTS showed better height and angle restoration
abilities, especially in patients with severe fracture. These
abilities might result in better VAS scores in severe fracture
patients treated by the BTS, even though there was no sig-
nificant difference between the HPDS and BTS groups in
the quality-of-life scores.
The cemented vertebral bodies and the increased height of
the collapsed vertebra changed the biomechanical property
of and increased the load on the adjacent vertebral fracture.
Literature reports on the incidence of sustained adjacent
fracture after PVP or PKP show conflicting findings. The
risks for new adjacent fractures are lower after PVP than
after PKP (30,31), while some systematic reviews showed
that PVP resulted in higher adjacent factures than did PKP
(11,32); finally, some other reviews reported that the fracture
risks of PVP and PKP were similar (33,34). The adjacent
fracture may be a consequence of osteoporosis. Komemushi
A et al. (35) thought that cement extravasation into the
intervertebral space increases the incidence of adjacent
fractures, which might explain why there was less adjacent
vertebral fracture in the HPDS group than in the BTS group
in this study. Since the classic PVP procedure usually induces
much higher leakage than the BTS, the HPDS using high-
viscosity cement decreased the leakage rate, thus decreasing
the incidence of adjacent fractures. This high-viscosity cement
injection system is similar to the Confidence Spinal Cement
System used by Georgy, B.A. In a?single-center retrospective
review of the Confidence device using high-viscosity cement
(36), a similar leakage rate was found in the Confidence
device and PKP groups. Herein, we found that the leakage
rate in the HPDS group was higher than that in the BTS
group but was significantly lower than that reported for PVP
using low- to medium-viscosity cement (29,36). This evidence
demonstrates that the HPDS with high-viscosity cement
effectively reduces the leakage rate compared with the classic
PVP device using low- to medium-viscosity cement.
It was difficult to determine whether surgery using the
HPDS was better than that using the BTS because better
Table 3 - Clinical assessments (mean±SD).
Parameters HPDS BTS
Preoperation VAS 7.1±1.2 7.3±1.1
RDQ 15.1±3.1 15.5±2.3
EQ-5D 0.32±0.29 0.34±0.31
SF-36 PCS 24.5±7.2 23.9±6.7
SF-36 MCS 44.3±13.1 45.7±13.9
ODI 62.6±8.2 61.5±7.5
Use of analgesic - No. (%) 105 (73) 112 (77)
1 week PO VAS 4.3±1.2 4.2±0.9
RDQ 13.1±2.1 12.8±2.0
EQ-5D 0.70±0.31 0.75±0.34
SF-36 PCS 32.5±5.6 31.6±6.1
SF-36 MCS 47.9±12.8 48.9±12.2
ODI 32.8±5.6 33.6±6.1
Use of analgesic - No. (%) 57 (41) 61 (43)
1 month PO VAS 3.9±1.5 4.2±1.6
RDQ 12.5±2.0 12.9±2.2
EQ-5D 0.76±0.29 0.79±0.35
SF-36 PCS 36.3±6.5 34.9±7.1
SF-36 MCS 50.2±13.8 47.5±14.4
ODI 30.2±6.2 31.6±6.9
Use of analgesic - No. (%) 33 (32) 35 (31)
3 months PO VAS 4.0±1.8 4.4±1.4
RDQ 11.9±2.4 12.5±2.3
EQ-5D 0.73±0.31 0.76±0.32
SF-36 PCS 37.1±5.2 34.5±5.6*
SF-36 MCS 47.5±14.1 50.9±13.2
ODI 29.5±6.3 32.8±6.5*
Use of analgesic - No. (%) 17 (24) 16 (20)
6 months PO VAS 3.8±1.6 4.3±1.9
RDQ 12.1±2.6 12.7±1.9
EQ-5D 0.74±0.35 0.78±0.33
SF-36 PCS 36.9±4.9 34.9±4.5*
SF-36 MCS 46.8±13.1 50.5±14.2
ODI 30.4±6.7 34.2±6.8*
Use of analgesic - No. (%) 9 (15) 11 (16)
12 months PO VAS 4.8±1.6 4.4±1.5
RDQ 11.6±1.5 11.8±1.9
EQ-5D 0.67±0.23 0.77±0.21*
SF-36 PCS 34.2±4.8 35.5±4.5
SF-36 MCS 45.2±12.3 49.1±13.2
ODI 33.9±5.2 31.0±5.1*
Use of analgesic - No. (%) 6 (13) 4 (10)
24 months PO VAS 5.3±1.8 4.6±1.9
RDQ 12.1±1.9 11.4±2.1
EQ-5D 0.62±0.19 0.73±0.22*
SF-36 PCS 32.3±5.3 34.4±4.7
SF-36 MCS 42.5±13.3 47.6±14.1
ODI 32.5±4.3 30.7±4.8
Use of analgesic - No. (%) 6 (20) 7 (23)
*po0.05 versus HPDS.
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designed random control trials are needed. In contrast with
other studies (29,36) related to PVP, this is a random, pro-
spective study. Moreover, some limitations exist in this study.
First, some participants were lost to the long-term follow-up
over time. Second, large sample numbers are need for further
investigation.
’ CONCLUSION
Despite the difficulty of evaluating which one of the
two surgeries considered in this study is better, the overall
evidence shows that the use of the HPDS with high-viscosity
cement has similar outcomes to the BTS in the clinical treat-
ment of OVCFs. We suggest using the HPDS to treat mild
and moderate OVCFs and choosing the HPDS as an alter-
native method to treat severe OVCFs.
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